NeuroPace, Inc.
NPCE
$14.09
-$0.03-0.21%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 20.91% | 14.61% | 13.23% | 21.27% | 17.64% |
| Total Depreciation and Amortization | 10.12% | 8.69% | 9.98% | 10.72% | 10.22% |
| Total Amortization of Deferred Charges | 3.95% | -12.55% | -29.08% | -33.00% | -19.43% |
| Total Other Non-Cash Items | -2.85% | -2.59% | -7.01% | -10.80% | -8.69% |
| Change in Net Operating Assets | 26.41% | -114.21% | -80.54% | -382.00% | -119.48% |
| Cash from Operations | 38.68% | 1.12% | 5.75% | -2.12% | 8.89% |
| Capital Expenditure | -8.50% | 8.36% | -65.38% | -64.83% | -76.88% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -81.48% | -74.07% | -56.13% | -59.91% |
| Cash from Investing | -103.69% | -83.56% | -76.26% | -57.27% | -60.94% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 1,278.84% | 466.92% | 669.40% | 700.86% | -40.08% |
| Repurchase of Common Stock | -5,591.03% | -5,970.46% | -6,218.79% | -6,462.47% | -240.15% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 352.97% | 69.44% | 161.70% | 200.01% | -46.76% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 278.52% | -8.26% | 100.70% | 123.34% | -140.41% |